1. Home
  2. ANVS vs SQNS Comparison

ANVS vs SQNS Comparison

Compare ANVS & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • SQNS
  • Stock Information
  • Founded
  • ANVS 2008
  • SQNS 2003
  • Country
  • ANVS United States
  • SQNS France
  • Employees
  • ANVS N/A
  • SQNS N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • SQNS Semiconductors
  • Sector
  • ANVS Health Care
  • SQNS Technology
  • Exchange
  • ANVS Nasdaq
  • SQNS Nasdaq
  • Market Cap
  • ANVS 92.6M
  • SQNS 85.7M
  • IPO Year
  • ANVS 2020
  • SQNS 2011
  • Fundamental
  • Price
  • ANVS $2.73
  • SQNS $2.63
  • Analyst Decision
  • ANVS Strong Buy
  • SQNS Strong Buy
  • Analyst Count
  • ANVS 6
  • SQNS 1
  • Target Price
  • ANVS $31.40
  • SQNS $7.50
  • AVG Volume (30 Days)
  • ANVS 621.3K
  • SQNS 121.8K
  • Earning Date
  • ANVS 03-31-2025
  • SQNS 02-11-2025
  • Dividend Yield
  • ANVS N/A
  • SQNS N/A
  • EPS Growth
  • ANVS N/A
  • SQNS N/A
  • EPS
  • ANVS N/A
  • SQNS 2.00
  • Revenue
  • ANVS N/A
  • SQNS $36,762,000.00
  • Revenue This Year
  • ANVS N/A
  • SQNS $10.14
  • Revenue Next Year
  • ANVS N/A
  • SQNS $8.54
  • P/E Ratio
  • ANVS N/A
  • SQNS $1.32
  • Revenue Growth
  • ANVS N/A
  • SQNS 9.36
  • 52 Week Low
  • ANVS $2.44
  • SQNS $0.85
  • 52 Week High
  • ANVS $20.00
  • SQNS $7.18
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 23.71
  • SQNS 37.45
  • Support Level
  • ANVS $2.44
  • SQNS $2.47
  • Resistance Level
  • ANVS $5.50
  • SQNS $3.39
  • Average True Range (ATR)
  • ANVS 0.31
  • SQNS 0.22
  • MACD
  • ANVS -0.11
  • SQNS -0.08
  • Stochastic Oscillator
  • ANVS 11.28
  • SQNS 17.39

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: